The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
Even physicians are dealing with anxiety, some for the first time, says Joan Anzia, psychiatrist and professor at Northwestern University Feinberg School of Medicine. She often counsels those in the health care field and says this sense of mortality is even hitting them. “It’s been decades since physicians have had to endanger their own lives and put their own life at risk just by going to work,” she tells me when I call her.
–
Susan Mitchell, MD, a board-certified ob-gyn at Northwestern Medicine Delnor Hospital, explained that the rate of effectiveness is a direct result of the way Phexxi works. “It doesn’t necessarily kill the sperm,” Dr. Mitchell told POPSUGAR. “It just decreases their motility, so it’s harder for them to reach and fertilize an egg.”
–
Black children are 7 percent more likely to have food allergies than White children, according to a 2020 study by Ruchi Gupta, a pediatrician and professor at Northwestern University’s Feinberg School of Medicine. To be sure, the study shows that Asian children are 24 percent more likely than White children to have food allergies. But Black and Hispanic children are disproportionately more likely to live in poor communities, to have asthma and to suffer from systemic racism in the delivery of medical care.
–
Video from inside the intensive care unit at Chicago’s Northwestern Memorial Hospital shows front line workers battling coronavirus in plastic body armor. Illinois on Friday recorded its highest number of hospitalizations since early June, with 6,943. Hospitalizations in the state are up at least 85% in the last month.
–
[VIDEO – with Khalilah Gates, MD] For the second straight day, the U.S. set a new record for daily coronavirus cases, with more than 90,000 recorded on Thursday. The dramatic increase has led to a growing number of states putting tough new restrictions in place. NBC’s Kathy Park reports for TODAY from Chicago, where rules to curb the crisis are going into effect.
–
A new antibody-based drug shows promise in treating outpatients who have mild to severe COVID-19, according to initial results of research conducted in part at Cook County Health and Northwestern University.
–
Dr. Seth Trueger is tired of the pandemic. He misses his regular breakfast restaurant, which he now passes without stopping because of the risk of eating indoors. He misses his beard, which is now shaved because he wears masks every day. And he misses the old version of his job, when he didn’t have to calculate the risk of possible death with every action.Trueger is an emergency room doctor at Northwestern Memorial Hospital, where he has been on the front lines of COVID-19 since it was declared a pandemic in March.
–
“It’s baked into the system,” says Melissa Simon, vice chair for clinical research at the Department of Obstetrics and Gynecology at Northwestern University’s Feinberg School of Medicine and founding director of the Center for Health Equity Transformation at Northwestern. Once flawed research is published, she says, it can have a chilling effect on other scientists and create distrust among patients who might turn down the opportunity to participate in research studies and clinical trials. “Clearly there are papers out there that potentially do harm to advancing science.”
–
“(Outdoor dining) is definitely safer than indoor dining,” wrote Robert Murphy, executive director of Northwestern University’s Institute for Global Health and a professor of infectious diseases at the Feinberg School of Medicine, in an email. “The issue is who you are dining with because you will be pretty close while you eat. The more air movement, the better.”
–
Despite these setbacks, research continues on other potential COVID-19 therapies, like remdesivir, first formulated to treat Ebola, which was given emergency use authorization by the FDA for those with “severe COVID-19” in May. “We’re targeting a number of different proteins the virus needs for replication,” says Karla Satchell, a microbiologist at Northwestern University Feinberg School of Medicine in Chicago and a lead scientist for a team helping develop drugs to combat COVID-19. “We’re screening all of these drugs for their ability to stop the virus.”